Literature DB >> 20822767

Maternal high-fat intake predisposes nonalcoholic fatty liver disease in C57BL/6 offspring.

Bianca M Gregorio1, Vanessa Souza-Mello, Jorge J Carvalho, Carlos A Mandarim-de-Lacerda, Marcia B Aguila.   

Abstract

OBJECTIVE: This work aimed to verify the hypothesis that maternal intake of high-fat diet in critical periods of pregnancy and/or suckling period predisposes nonalcoholic fatty liver disease in adult C57BL/6 mice offspring. STUDY
DESIGN: Male pups were divided into 5 groups: (1) SC, from standard chow-fed dams; (2) G, from high-fat chow (HF)-fed dams during the gestation (G) period; (3) L, from HF-fed dams during the lactation (L) period; (4) GL, from HF-fed dams during the gestation and lactation (GL) periods; and (5) GL/HF, from HF-fed dams during GL, maintaining an HF diet from postweaning to adulthood. We analyzed body mass, plasma blood, and liver structure.
RESULTS: The G offspring showed insulin resistance and lower glucose transporter-2 expression. Hepatic steatosis was present in the G, L, GL, and mainly in GL/HF offspring. Sterol regulatory element-binding protein-1c expression was higher in G, GL, and GL/HF offspring.
CONCLUSION: Programming by HF chow predisposes hepatic adverse remodeling in the liver of adult offspring.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20822767     DOI: 10.1016/j.ajog.2010.06.042

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  41 in total

1.  Maternal high-fat diet is associated with altered pancreatic remodelling in mice offspring.

Authors:  Bianca Martins Gregorio; Vanessa Souza-Mello; Carlos Alberto Mandarim-de-Lacerda; Marcia Barbosa Aguila
Journal:  Eur J Nutr       Date:  2012-06-02       Impact factor: 5.614

2.  Developmental programming of the metabolic syndrome - critical windows for intervention.

Authors:  Mark H Vickers
Journal:  World J Diabetes       Date:  2011-09-15

Review 3.  Early life programming in mice by maternal overnutrition: mechanistic insights and interventional approaches.

Authors:  Lisa M Nicholas; Susan E Ozanne
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-04-15       Impact factor: 6.237

4.  Diets rich in saturated fat and/or salt differentially modulate atrial natriuretic peptide and renin expression in C57BL/6 mice.

Authors:  Milton Vieira Costa; Caroline Fernandes-Santos; Tatiane da Silva Faria; Marcia Barbosa Aguila; Carlos Alberto Mandarim-de-Lacerda
Journal:  Eur J Nutr       Date:  2011-04-17       Impact factor: 5.614

Review 5.  Endocrine-disrupting chemicals and fatty liver disease.

Authors:  Charles E Foulds; Lindsey S Treviño; Brian York; Cheryl L Walker
Journal:  Nat Rev Endocrinol       Date:  2017-05-19       Impact factor: 43.330

6.  Placental changes caused by food restriction during early pregnancy in mice are reversible.

Authors:  Jennifer L Harper; Gerialisa A Caesar; Kathleen A Pennington; J Wade Davis; Laura Clamon Schulz
Journal:  Reproduction       Date:  2015-09       Impact factor: 3.906

7.  Prevalence of NAFLD in Guatemala following exposure to a protein-energy nutrition intervention in early life.

Authors:  Ahlia Sekkarie; Siran He; Jean A Welsh; Usha Ramakrishnan; Aryeh D Stein; Miriam B Vos
Journal:  Ann Hepatol       Date:  2020-05-16       Impact factor: 2.400

Review 8.  Developmental origins of nonalcoholic fatty liver disease.

Authors:  David E Brumbaugh; Jacob E Friedman
Journal:  Pediatr Res       Date:  2013-11-05       Impact factor: 3.756

9.  Maternal nutritional history modulates the hepatic IGF-IGFBP axis in adult male rat offspring.

Authors:  Timothy Smith; Deborah M Sloboda; Richard Saffery; Eric Joo; Mark H Vickers
Journal:  Endocrine       Date:  2013-08-21       Impact factor: 3.633

Review 10.  Effects of Maternal Obesity on Fetal Programming: Molecular Approaches.

Authors:  Caterina Neri; Andrea G Edlow
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-03       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.